The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers

Backgroundwe evaluated the concordance between immunohistochemical p53 staining and TP53 mutations in a series of HGSOC. Moreover, we searched for prognostic differences between p53 overexpression and null expression groups.Methodspatients affected by HGSOC were included. For each case p53 immunohis...

Descrición completa

Detalles Bibliográficos

Principais autores:	Chiara M. Biatta, Michele Paudice, Marco Greppi, Veronica Parrella, Alessia Parodi, Giuseppa De Luca, Gianna Maria Cerruti, Serafina Mammoliti, Cinzia Caroti, Paola Menichini, Gilberto Fronza, Silvia Pesce, Emanuela Marcenaro, Valerio G. Vellone
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2023-08-01
Series:	Frontiers in Immunology
Assuntos:	high grade serous ovarian carcinoma TP53 immunohistochemistry sanger sequencing ovarian cancer
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1221605/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!